Index RUT
P/E -
EPS (ttm) -2.12
Insider Own 4.70%
Shs Outstand 50.77M
Perf Week 18.09%
Market Cap 3.17B
Forward P/E -
EPS next Y -1.50
Insider Trans -13.00%
Shs Float 48.98M
Perf Month 32.63%
Income -103.37M
PEG -
EPS next Q -0.52
Inst Own 88.29%
Short Float 10.94%
Perf Quarter 30.25%
Sales 156.33M
P/S 20.30
EPS this Y 13.22%
Inst Trans -6.33%
Short Ratio 10.06
Perf Half Y 130.46%
Book/sh 5.53
P/B 11.17
EPS next Y 22.70%
ROA -30.98%
Short Interest 5.36M
Perf Year 116.25%
Cash/sh 4.39
P/C 14.07
EPS next 5Y 10.80%
ROE -47.29%
52W Range 24.83 - 63.26
Perf YTD 47.32%
Dividend Est. -
P/FCF -
EPS past 5Y -23.27%
ROI -30.07%
52W High -2.40%
Beta 0.94
Dividend TTM -
Quick Ratio 7.44
Sales past 5Y 142.74%
Gross Margin 51.66%
52W Low 148.65%
ATR (14) 3.02
Dividend Ex-Date -
Current Ratio 8.52
EPS Y/Y TTM 3.57%
Oper. Margin -69.37%
RSI (14) 75.46
Volatility 6.81% 5.62%
Employees 626
Debt/Eq 0.31
Sales Y/Y TTM 83.44%
Profit Margin -66.12%
Recom 1.22
Target Price 58.57
Option/Short Yes / Yes
LT Debt/Eq 0.30
EPS Q/Q 19.49%
Payout -
Rel Volume 1.92
Prev Close 60.61
Sales Surprise 7.11%
EPS Surprise 8.16%
Sales Q/Q 82.51%
Earnings May 01 BMO
Avg Volume 532.41K
Price 61.74
SMA20 19.54%
SMA50 24.29%
SMA200 54.35%
Trades
Volume 1,020,723
Change 1.86%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-11-23 Initiated
Piper Sandler
Overweight
$42
May-31-23 Initiated
William Blair
Outperform
Oct-31-22 Initiated
BTIG Research
Neutral
Oct-25-22 Initiated
Truist
Buy
$58
Sep-02-22 Initiated
Wells Fargo
Overweight
$49
Jul-15-22 Initiated
KeyBanc Capital Markets
Overweight
$47
Jun-23-22 Initiated
B. Riley Securities
Buy
$53
Oct-11-21 Initiated
SVB Leerink
Outperform
$46
Oct-11-21 Initiated
Guggenheim
Buy
$45
Oct-11-21 Initiated
Goldman
Neutral
$37
Oct-11-21 Initiated
Cowen
Outperform
$50
Oct-11-21 Initiated
BofA Securities
Buy
$48
Show Previous Ratings
May-02-24 08:15AM
May-01-24 03:59PM
(Investor's Business Daily) +14.40%
01:53PM
12:13PM
08:25AM
07:00AM
Loading…
07:00AM
Apr-29-24 08:00AM
Apr-23-24 08:00AM
Apr-04-24 04:04PM
Apr-02-24 04:03PM
Mar-20-24 07:01PM
Mar-08-24 01:30AM
Mar-06-24 11:55PM
Feb-28-24 12:00PM
(Thomson Reuters StreetEvents)
10:00AM
04:02PM
Loading…
Feb-27-24 04:02PM
Feb-20-24 10:00AM
Feb-12-24 04:05PM
Feb-10-24 02:07AM
Feb-08-24 05:30PM
Jan-11-24 11:02PM
Jan-10-24 03:51AM
Jan-08-24 05:00PM
Dec-16-23 07:02AM
Dec-10-23 01:15AM
Dec-09-23 01:05AM
Dec-05-23 02:44PM
(Investor's Business Daily)
Nov-15-23 01:03AM
Nov-13-23 04:03PM
Nov-06-23 09:55AM
04:07PM
Loading…
Nov-02-23 04:07PM
09:33AM
(Thomson Reuters StreetEvents)
Nov-01-23 04:02PM
Oct-25-23 10:02AM
Oct-16-23 04:05PM
10:23AM
08:43AM
Oct-12-23 08:00AM
Sep-20-23 08:00AM
Sep-12-23 08:00AM
Aug-22-23 08:00AM
Aug-17-23 04:05PM
Aug-16-23 08:00AM
Aug-11-23 09:36AM
Aug-02-23 07:14AM
Aug-01-23 10:10PM
04:06PM
Jul-27-23 08:35AM
07:00AM
Jul-11-23 04:03PM
May-17-23 06:12AM
May-14-23 02:57PM
Apr-28-23 08:00AM
Apr-27-23 12:52PM
08:25AM
07:00AM
Apr-24-23 10:00AM
Apr-20-23 10:03AM
Apr-06-23 06:33AM
Apr-05-23 04:03PM
Apr-03-23 08:00AM
Mar-30-23 04:05PM
Mar-27-23 08:08AM
Mar-07-23 07:00AM
Mar-02-23 04:05PM
Mar-01-23 09:52AM
(Thomson Reuters StreetEvents)
Feb-28-23 05:25PM
04:03PM
Feb-22-23 05:33AM
Feb-16-23 09:15AM
Feb-13-23 04:02PM
Jan-09-23 08:00AM
Dec-14-22 04:05PM
Dec-12-22 03:44PM
Nov-09-22 07:32AM
Nov-03-22 05:55PM
04:03PM
Oct-27-22 10:02AM
07:37AM
Oct-12-22 08:00AM
Oct-10-22 08:00AM
Oct-04-22 10:15AM
Oct-03-22 09:16AM
Sep-19-22 08:00AM
Sep-15-22 06:15AM
Aug-22-22 04:03PM
Aug-05-22 05:30PM
Aug-04-22 04:03PM
Jul-14-22 04:02PM
Jul-10-22 08:32AM
Jun-16-22 02:30PM
(Investor's Business Daily)
Jun-09-22 09:01AM
08:00AM
May-10-22 06:20AM
May-05-22 04:02PM
Apr-28-22 08:00AM
Apr-12-22 04:02PM
Apr-11-22 08:00AM
Mar-10-22 06:03AM
Mar-08-22 04:00PM
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Zadno Reza President, CEO Mar 18 '24 Sale 48.83 5,391 263,243 241,319 Mar 20 04:46 PM Waters Kevin EVP, CFO Mar 18 '24 Sale 48.83 1,024 50,002 102,149 Mar 20 04:48 PM Nouri Alaleh EVP, CLO, CORP. SEC. Mar 18 '24 Sale 48.83 441 21,534 62,472 Mar 20 04:52 PM Shiblaq Hisham EVP, Chief Comm. Officer Mar 18 '24 Sale 48.83 244 11,915 55,860 Mar 20 04:41 PM Waters Kevin EVP, CFO Mar 15 '24 Option Exercise 4.53 53,757 243,692 103,173 Mar 18 06:05 PM Zadno Reza President, CEO Mar 06 '24 Sale 46.67 9,179 428,384 246,710 Mar 07 07:50 PM Waters Kevin EVP, CFO Mar 06 '24 Sale 46.67 3,435 160,311 49,416 Mar 07 07:51 PM Nouri Alaleh EVP, CLO, CORP. SEC. Mar 06 '24 Sale 46.67 2,749 128,296 62,913 Mar 07 07:53 PM Shiblaq Hisham EVP, Chief Comm. Officer Mar 06 '24 Sale 46.67 1,759 82,093 56,104 Mar 07 07:50 PM Krummel Thomas M Director Mar 04 '24 Sale 48.53 20,000 970,643 65,631 Mar 06 04:50 PM Waters Kevin EVP, CFO Feb 12 '24 Option Exercise 4.52 22,349 101,017 55,872 Feb 13 04:37 PM Waters Kevin EVP, CFO Feb 12 '24 Sale 50.16 22,349 1,121,062 33,523 Feb 13 04:37 PM Waters Kevin EVP, CFO Feb 09 '24 Option Exercise 4.52 28,677 129,620 62,200 Feb 09 05:09 PM Nouri Alaleh EVP, CLO, CORP. SEC. Feb 09 '24 Option Exercise 5.18 14,694 76,115 62,045 Feb 09 05:02 PM Waters Kevin EVP, CFO Feb 09 '24 Sale 50.09 28,677 1,436,379 33,523 Feb 09 05:09 PM Nouri Alaleh EVP, CLO, CORP. SEC. Feb 09 '24 Sale 49.97 14,694 734,314 47,351 Feb 09 05:02 PM Nouri Alaleh EVP, CLO, CORP. SEC. Feb 07 '24 Option Exercise 5.18 5,306 27,485 52,657 Feb 09 05:02 PM Waters Kevin EVP, CFO Feb 07 '24 Option Exercise 4.52 904 4,086 34,427 Feb 09 05:09 PM Nouri Alaleh EVP, CLO, CORP. SEC. Feb 07 '24 Sale 49.95 5,306 265,053 47,351 Feb 09 05:02 PM Waters Kevin EVP, CFO Feb 07 '24 Sale 50.00 904 45,200 33,523 Feb 09 05:09 PM Waters Kevin EVP, CFO Jan 09 '24 Option Exercise 4.52 17,310 78,241 50,833 Jan 11 05:03 PM Nouri Alaleh EVP, CLO, CORP. SEC. Jan 09 '24 Option Exercise 4.56 16,000 72,960 63,351 Jan 11 05:12 PM Waters Kevin EVP, CFO Jan 09 '24 Sale 45.07 17,310 780,247 33,523 Jan 11 05:03 PM Nouri Alaleh EVP, CLO, CORP. SEC. Jan 09 '24 Sale 44.97 16,000 719,475 47,351 Jan 11 05:12 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 15 '23 Option Exercise 4.56 11,796 53,790 58,729 Dec 15 06:28 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 15 '23 Sale 42.97 11,796 506,843 46,933 Dec 15 06:28 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 14 '23 Option Exercise 4.56 3,204 14,610 50,137 Dec 15 06:28 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 14 '23 Sale 42.95 3,204 137,618 46,933 Dec 15 06:28 PM Waters Kevin EVP, CFO Dec 13 '23 Option Exercise 4.52 71,465 323,022 104,988 Dec 15 06:19 PM Waters Kevin EVP, CFO Dec 13 '23 Sale 40.05 71,465 2,862,216 33,523 Dec 15 06:19 PM Waters Kevin EVP, CFO Dec 08 '23 Option Exercise 4.52 6,888 31,134 48,608 Dec 08 05:58 PM Waters Kevin EVP, CFO Dec 08 '23 Sale 40.02 6,888 275,640 33,523 Dec 08 05:58 PM Waters Kevin EVP, CFO Dec 07 '23 Option Exercise 4.52 3,837 17,343 41,720 Dec 08 05:58 PM Waters Kevin EVP, CFO Dec 07 '23 Sale 40.00 3,837 153,480 40,411 Dec 08 05:58 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 06 '23 Option Exercise 4.52 6,096 27,554 53,029 Dec 08 08:05 PM Waters Kevin EVP, CFO Dec 06 '23 Option Exercise 4.52 4,360 19,707 37,883 Dec 08 05:58 PM MOLL FREDERIC H Director Dec 06 '23 Sale 38.75 79,000 3,061,355 808,233 Dec 08 05:33 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 06 '23 Sale 39.96 6,096 243,572 46,933 Dec 08 08:05 PM Waters Kevin EVP, CFO Dec 06 '23 Sale 40.02 4,360 174,493 44,248 Dec 08 05:58 PM Wood Morgan Colby Director Nov 13 '23 Sale 32.19 25,000 804,810 112,425 Nov 14 04:12 PM Zadno Reza President, CEO Oct 18 '23 Option Exercise 4.37 5,148 22,497 200,956 Oct 18 04:28 PM Nouri Alaleh EVP, CLO, CORP. SEC. Jul 27 '23 Option Exercise 4.52 7,903 35,722 54,836 Jul 31 04:05 PM Nouri Alaleh EVP, CLO, CORP. SEC. Jul 27 '23 Sale 40.00 7,903 316,129 46,933 Jul 31 04:05 PM Waters Kevin EVP, CFO Jun 15 '23 Sale 35.12 22,631 794,912 33,523 Jun 15 05:09 PM Nouri Alaleh EVP, CLO, CORP. SEC. May 08 '23 Option Exercise 4.52 12,123 54,796 46,933 May 10 04:41 PM
Index RUT
P/E 20.21
EPS (ttm) 2.50
Insider Own 0.89%
Shs Outstand 57.72M
Perf Week 4.99%
Market Cap 2.91B
Forward P/E 21.33
EPS next Y 2.37
Insider Trans -1.30%
Shs Float 57.24M
Perf Month 11.44%
Income 144.04M
PEG 1.87
EPS next Q 0.46
Inst Own 83.21%
Short Float 2.05%
Perf Quarter 9.84%
Sales 934.28M
P/S 3.12
EPS this Y 202.62%
Inst Trans -3.07%
Short Ratio 3.02
Perf Half Y 3.64%
Book/sh 25.41
P/B 1.99
EPS next Y -14.10%
ROA 3.32%
Short Interest 1.17M
Perf Year -9.60%
Cash/sh 1.53
P/C 33.01
EPS next 5Y 10.80%
ROE 10.42%
52W Range 43.50 - 58.30
Perf YTD -2.74%
Dividend Est. 1.11 (2.19%)
P/FCF -
EPS past 5Y -7.76%
ROI 5.72%
52W High -13.46%
Beta 0.48
Dividend TTM 1.06 (2.10%)
Quick Ratio 0.52
Sales past 5Y 2.80%
Gross Margin 38.28%
52W Low 15.98%
ATR (14) 1.13
Dividend Ex-Date Feb 09, 2024
Current Ratio 0.56
EPS Y/Y TTM 84.85%
Oper. Margin 19.11%
RSI (14) 72.13
Volatility 2.07% 2.26%
Employees 1266
Debt/Eq 0.91
Sales Y/Y TTM 16.13%
Profit Margin 15.42%
Recom 2.80
Target Price 52.75
Option/Short Yes / Yes
LT Debt/Eq 0.72
EPS Q/Q 403.31%
Payout 114.16%
Rel Volume 0.60
Prev Close 49.83
Sales Surprise 47.27%
EPS Surprise 807.73%
Sales Q/Q 106.52%
Earnings Apr 25 BMO
Avg Volume 387.26K
Price 50.45
SMA20 9.07%
SMA50 9.14%
SMA200 3.23%
Trades
Volume 232,355
Change 1.24%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-04-24 Upgrade
UBS
Sell → Neutral
Oct-25-23 Downgrade
Wells Fargo
Equal Weight → Underweight
$56 → $47
Jul-28-23 Upgrade
Janney
Neutral → Buy
$66
Jun-28-23 Upgrade
Wells Fargo
Underweight → Equal Weight
$58 → $56
Jun-14-23 Downgrade
UBS
Neutral → Sell
$59 → $51
Jan-25-22 Upgrade
Seaport Research Partners
Sell → Neutral
$78
Apr-16-21 Downgrade
Seaport Global Securities
Neutral → Sell
Mar-04-21 Downgrade
Wells Fargo
Equal Weight → Underweight
$57 → $53
Jan-08-21 Downgrade
Janney
Buy → Neutral
Jul-13-20 Downgrade
Boenning & Scattergood
Outperform → Neutral
May-20-20 Initiated
Seaport Global Securities
Neutral
May-01-20 Upgrade
Janney
Neutral → Buy
May-01-20 Upgrade
Boenning & Scattergood
Neutral → Outperform
$52
Jun-10-19 Initiated
Boenning & Scattergood
Neutral
Mar-27-19 Downgrade
Wells Fargo
Market Perform → Underperform
$50
Dec-06-18 Upgrade
Robert W. Baird
Neutral → Outperform
Sep-17-18 Initiated
Evercore ISI
In-line
Aug-27-18 Resumed
Wells Fargo
Market Perform
Apr-03-18 Upgrade
Wells Fargo
Underperform → Market Perform
Jan-17-18 Downgrade
Hilliard Lyons
Neutral → Underperform
Show Previous Ratings
May-02-24 02:21AM
Apr-30-24 08:50AM
Apr-28-24 09:57AM
Apr-26-24 01:06AM
(Thomson Reuters StreetEvents)
Apr-25-24 10:12AM
09:10AM
Loading…
09:10AM
08:36AM
07:42AM
(Associated Press Finance)
07:34AM
Apr-24-24 04:15PM
Apr-23-24 12:16PM
Apr-18-24 05:00PM
Apr-17-24 06:08PM
Apr-10-24 04:15PM
Apr-09-24 04:15PM
12:54PM
Loading…
Apr-05-24 12:54PM
Apr-04-24 05:37PM
Mar-28-24 04:15PM
Mar-18-24 04:15PM
Mar-14-24 07:30AM
Mar-11-24 09:00AM
Mar-05-24 10:21AM
Mar-04-24 07:45AM
Mar-01-24 01:38AM
(Thomson Reuters StreetEvents)
Feb-29-24 11:28AM
10:15AM
09:31AM
09:10AM
(Associated Press Finance)
09:00AM
Feb-26-24 10:51AM
05:11AM
Loading…
Feb-09-24 05:11AM
Feb-08-24 05:20PM
Jan-31-24 04:15PM
02:51PM
Jan-29-24 09:35AM
Jan-26-24 07:30PM
Jan-25-24 07:58PM
05:28PM
Jan-16-24 06:15PM
Jan-12-24 09:35AM
07:54AM
Jan-11-24 04:15PM
Jan-05-24 07:17AM
Jan-04-24 09:00AM
Jan-03-24 04:15PM
09:00AM
06:57AM
Jan-02-24 04:15PM
Dec-18-23 04:30PM
Dec-06-23 04:30PM
Dec-05-23 10:25AM
Nov-29-23 04:15PM
Nov-04-23 09:02AM
Nov-03-23 07:13AM
Oct-31-23 06:21AM
Oct-30-23 09:09AM
06:31AM
Oct-27-23 09:02AM
06:58AM
(Thomson Reuters StreetEvents)
Oct-26-23 04:15PM
11:26AM
10:15AM
10:05AM
09:10AM
(Associated Press Finance)
09:00AM
Oct-25-23 04:15PM
Oct-23-23 08:09AM
Oct-17-23 08:54AM
Oct-12-23 04:15PM
Oct-10-23 05:36AM
Oct-05-23 04:15PM
09:39AM
Oct-04-23 04:15PM
08:21AM
Oct-03-23 09:15AM
Sep-29-23 12:10PM
Sep-15-23 11:29AM
Sep-14-23 04:15PM
Sep-07-23 04:15PM
Sep-01-23 02:43PM
Aug-31-23 08:00AM
Aug-25-23 12:00PM
Aug-23-23 09:42AM
Aug-16-23 07:44AM
Aug-09-23 04:15PM
Aug-08-23 12:03PM
Aug-07-23 08:45AM
Aug-01-23 04:15PM
Jul-31-23 08:45AM
Jul-29-23 10:03AM
Jul-28-23 05:15PM
08:48AM
02:48AM
(Thomson Reuters StreetEvents)
Jul-27-23 07:05AM
05:51AM
05:45AM
Jul-26-23 06:05PM
04:10PM
05:00AM
Jul-25-23 08:20AM
California Water Service Group is a holding company, which engages in the provision of water utility and other related services in California, Washington, New Mexico, and Hawaii through its wholly owned subsidiaries. The firm is involved in the production, purchase, storage, treatment, testing, distribution and sale of water for domestic, industrial, public, and irrigation uses, and fire protection. It also provides non-regulated water-related services under agreements with municipalities and other private companies. The company was founded in 1926 and is headquartered in San Jose, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Krummel Thomas M Director May 01 '24 Sale 50.00 2,220 111,000 23,873 May 01 05:48 PM Krummel Thomas M Director Jan 03 '24 Sale 51.90 555 28,804 26,066 Jan 04 04:27 PM Krummel Thomas M Director Dec 20 '23 Sale 53.45 555 29,665 26,621 Dec 20 05:42 PM Mortensen Michelle R Corporate Secretary Dec 12 '23 Sale 52.56 675 35,478 8,983 Dec 12 06:48 PM Krummel Thomas M Director Nov 15 '23 Sale 51.77 555 28,731 27,731 Nov 15 05:35 PM Krummel Thomas M Director Nov 02 '23 Sale 50.00 2,220 111,000 28,286 Nov 03 08:04 PM Kuta Robert J VP, Engineering May 05 '23 Sale 56.79 1,000 56,790 12,916 May 05 05:11 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite